期刊文献+

A+C群脑脊髓膜炎球菌多糖菌苗生产工艺与内毒素含量研究 被引量:3

Study of production process and endotoxin content of group A+C Meningococcal polysaccharide vaccine
下载PDF
导出
摘要 A群及C群流脑多糖抗原用 10 0 0 0 0×g离心或不经超速离心处理 ,经用鲎试验法测定内毒素含量 ,2种工艺生产的A群及C群流脑多糖抗原的内毒素含量均很低。用未经超速离心处理的A群及C群流脑多糖抗原制成的A +C群流脑多糖菌苗 ,经鲎试验法测定 ,内毒素含量也很低 ;经家兔升温法进行热原质试验 ,家兔体温未明显升高。证明A +C群流脑多糖菌苗生产工艺不经 10 0 0 0 0×g离心去除内毒素步骤是可行的。所制备的流脑多糖抗原内毒素含量符合要求。 Group A and C Meningococcal polysaccharide were centrifuged with 100 000×g or not treated with ultracentrifuge.Resulting Group A and C Meningococcal polysaccharide were tested by LAL test,the endotoxin content was very low.There is no difference between two process preparation in endotoxin content.Group A+C Meningococcal polysaccharide vaccine which was prepared by Group A and C Meningococcal polysaccharide without ultracentrifuge was tested by LAL test,the endotoxin content was also very low,the pyrogen of Group A+C Meningococcal polysaccharidevaccine was tested with rabbits,the body temperature of rabbits did not increase significantly.This study indicated production process without ultracentrifuge of Group A+C Meningococcal polysaccharide vaccine is reliable,the endotoxin content of resulting Group A and C Meningococcal polysaccharide are satisfying.
出处 《微生物学免疫学进展》 2000年第2期11-13,共3页 Progress In Microbiology and Immunology
关键词 A+C群 内毒素 汉脑多糖菌苗 生产工艺 热原检测 Group A and C Meningococcal polysaccharide Group A+C Meningococcal polysaccharide vaccine endotoxin.
  • 相关文献

参考文献1

二级参考文献4

共引文献1

同被引文献15

  • 1李文春,戴晓畅,杨美峰,钱雯,施競,陈兰萍,陈燕,黄镇.W_(135)和Y群脑膜炎球菌培养和多糖纯化[J].中国生物制品学杂志,2005,18(3):236-237. 被引量:6
  • 2Andrew G, Denise H, Mery M, et al. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membranc vesicles [J]. Vaccine, 2005, 23 (2):2210-2213.
  • 3Gotschlich EC, Liu TY, Artenstein MS. Human immunity to the meningoeoecus Ⅲ. Preparation and immunochemical properties of the group A, group B, and group C meningococeal polysaccharides [J]. JExDMed, 1969, 129 (1): 1349-1365.
  • 4Goldscheneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus I: the role of humoral antibodies [J].JEepMed, 1969, 129 (1): 1307-1326.
  • 5Gold R, Artenstein MS. Field trial of group C. meningococcal polysaccharide vaccine[ J ]. Bull WHO 1971,45: 279-282.
  • 6Ambrosch F, Wiedermann G, Grooy P, et al. Immunogenicity and side-effect of a new tetravalent meningococcal polysaccharied vaccine[J]. Bull WHO 1983,61: 317-323.
  • 7The requirement for meningococcal Polysaccharide vaccine[S].TRS No. 594. WHO, 1976 ,P50-73.
  • 8The requirement for meningococcal polysaccharide vaccine (updated) [S]. TRS No. 658. WHO, 1981, P174-183.
  • 9A群脑膜炎球菌多糖疫苗制造及检定规程[S].中国生物制品规程(一部).1995年版.北京:中国人口出版社,1995,81-83.
  • 10流脑杀菌抗体测定操作细则[S].全国流脑杀菌抗体测定法标准化研究协作组,1984.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部